According to Data Bridge Market Research new Market report, global ambulatory infusion pumps market will account to growth at a significant CAGR during the forecast period of 2019 to 2026.

Access Full Report at https://databridgemarketresearch.com/reports/global-ambulatory-infusion-pumps-market/

Global Ambulatory Infusion Pumps Market:

Ambulatory infusion pumps are mobile medical equipment that are used for delivering fluids, in the form of nutrients, medicines, and are used in treatment of various diseases. They work on the same principle of infusion pumps but are mobile and transportable meaning they can be moved along with the patient to different places. They are majorly used in home cares, and various specialty clinics.

Segmentation: Global Ambulatory Infusion Pumps Market

Global ambulatory infusion pumps market is segmented on the basis of product, end-user and geography.

By Product (Disposable Infusion Pumps, Chemotherapy Infusion Pumps), End-User (Hospitals, Clinics) and Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa)

FACTORS DRIVING GROWTH IN AMBULATORY INFUSION PUMPS MARKET

Increasing levels of innovations and product launches adopted by the major players

• In August, 2017, Smiths Medical received FDA 510k clearance on wireless ambulatory infusion pump. The new system will help the hospitals increase efficiencies, reduce costs and improve patient outcomes.
• In April, 2016, Smiths Medical had introduced a new wireless ambulatory infusion system in the brand name of CADD®-Solis in Australia, New Zealand, Ireland and the United Kingdom. This system offers two-way wireless communication of infusion data in between the CADD®-Solis pump and the PharmGuard® Server software installed on the hospital’s network and helps to increase efficiency and safety, reduce costs and improve patient outcomes.

Key Market Competitors: Global Ambulatory Infusion Pumps Market

Few of the major competitors currently working in the ambulatory infusion pumps market are Medtronic, Baxter, B. Braun Melsungen AG, Fresenius Kabi AG, Hospira Inc., Smiths Medical, Moog, Inc., Medline Industries, Inc., ZynoMed.com, Sorenson Medical Products, Inc., BD., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd and Micrel Medical Devices S.A.

Browse Related Reports:

Global Implantable Infusion Pumps Market By Product (Piston Type Infusion Pumps, Creeping Type Infusion Pumps), Application (Cancer Treatment, Spasticity, Analgesia, Diabetes Mellitus, Others), End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), Geography (Europe, North America, Asia Pacific, South America and Middle East & Africa.) – Industry Trends & Forecast to 2026

https://databridgemarketresearch.com/reports/global-implantable-infusion-pumps-market/

Global Implantable Drug Delivery Market By Product Type (Implantable Bio-Absorbable Stents, Implantable Contraceptive Drug Delivery Devices, Implantable Intraocular Drug Delivery Devices, Implantable Coronary Drug Eluting Stents, Implantable Brachytherapy Seeds And Implantable Drug Infusion Pumps), Technology, Application, Geography (North America, South America, Europe, Asia-Pacific, Middle East And Africa)- Industry Trends and Forecast to 2025

https://databridgemarketresearch.com/reports/global-implantable-drug-delivery-market/

Global Drug – Device Combination Market, By Product (Infusion Pumps, Orthopedic Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Drug Eluting Stents, Wound Care Products, Inhalers, Antimicrobial Catheters), Application (Cardio-Vascular Diseases, Diabetes, Respiratory Diseases), End-Users (Hospitals, Clinics, Medical Laboratories, Home-Care), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025

https://databridgemarketresearch.com/reports/global-drug-device-combination-market/